Feedback / Questions
BSM-1516 - Blacksmith Medicines
https://www.prnewswire.com/news-releases/blacksmith-medicines-to-highlight-preclinical-oncology-data-demonstrating-a-potent-and-selective-fen1-inhibitor-has-synergy-with-multiple-ddr-drug-classes-at-aacr-annual-meeting-2024-302112741.html
Apr 10, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next